SEC 13F Intelligence

Commodore Capital LP / CCCC

Commodore Capital LP’s C4 Therapeutics Inc Position

Does Commodore Capital LP own C4 Therapeutics Inc (CCCC)? Not currently — the last reported position was 3.41M shares worth $19M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$19M
Q3 2024
Shares
3.41M
% of Portfolio
+1.21%
Quarters Held
10
position exited

Position History CCCC

Reported value by quarter
Q4 ’20: $16MQ4 ’20Q1 ’21: $18MQ2 ’21: $18MQ2 ’21Q3 ’21: $21MQ4 ’21: $15MQ4 ’21Q1 ’22: $12MQ4 ’23: $21MQ4 ’23Q1 ’24: $28MQ2 ’24: $16MQ2 ’24Q3 ’24: $19Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20243.41M$19M+1.21%
Q2 20243.41M$16M+1.08%
Q1 20243.41M$28M+1.86%
Q4 20233.80M$21M+1.88%
Q1 2022481.1K$12M+2.61%
Q4 2021481.1K$15M+3.59%
Q3 2021481.1K$21M+5.67%
Q2 2021481.1K$18M+6.27%
Q1 2021481.1K$18M+7.00%
Q4 2020481.1K$16M+8.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Commodore Capital LP’s full portfolio or all institutional holders of CCCC.